Alginic acid/aluminum hydroxide/magnesium carbonate Pregnancy and Breast Feeding Warnings
Alginic acid/aluminum hydroxide/magnesium carbonate is also known as: Acid Gone, Acid Gone Extra Strength, Alenic Alka, Gaviscon Extra Relief Formula, Gaviscon Extra Strength, Gaviscon Extra Strength Liquid, Gaviscon Regular Strength Liquid, Genaton, Heartburn Antacid Extra Strength
Overview
If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Aluminum/Magnesium Suspension while you are pregnant. If you are or will be breast-feeding while you use Aluminum/Magnesium Suspension, check with your doctor. Discuss any possible risks to your baby.
Alginic acid/aluminum hydroxide/magnesium carbonate Pregnancy Warnings
Magnesium carbonate, aluminum hydroxide and alginic acid have not been formally assigned to a pregnancy category by the FDA. There are no controlled data in human pregnancy. Other magnesium salts (such as magnesium sulfate) have been used extensively during pregnancy in large doses with no reports of congenital defects. Magnesium carbonate, aluminum hydroxide and alginic acid should only be given in pregnancy when benefit outweighs risk.
In a review of 229,101 deliveries to Michigan Medicaid patients, 351 first-trimester exposures to aluminum hydroxide were recorded and 996 exposures any time during pregnancy. A total of 14 birth defects were reported with first trimester exposure (15 expected) and included (observed/expected) 5/4 cardiovascular defects, 2/0.5 oral clefts, 1 polydactyly, and 1 hypospadias. Data are not available for magnesium carbonate. However, for magnesium hydroxide, 341 first-trimester exposures were recorded as well as 974 exposures any time during pregnancy. A total of 14 birth defects were reported with first trimester exposure (14 expected) and included (observed/expected) 5/3 cardiovascular defects, 2/0.8 polydactyly, and one hypospadias. These data do not support an association between aluminum hydroxide or magnesium hydroxide ingestion and adverse fetal outcome. (written communication, Franz Rosa, MD, Food and Drug Administration, 1994)
Alginic acid/aluminum hydroxide/magnesium carbonate Lactation Warnings
There are no data on the excretion of alginic acid, aluminum hydroxide or magnesium carbonate into human milk.
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
